Stock ACHC ACADIA HEALTHCARE COMPANY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Acadia Healthcare Company, Inc.

Equities

ACHC

US00404A1097

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
73.59 USD +0.29% Intraday chart for Acadia Healthcare Company, Inc. +4.89% -5.36%
Apr. 26 North American Morning Briefing : Tech Still in -2- DJ
Apr. 25 Deutsche Bank Upgrades Acadia Healthcare to Hold From Sell, Price Target is $70 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,942 4,473 5,459 7,489 7,171 6,802 - -
Enterprise Value (EV) 1 5,967 7,216 6,822 8,777 8,442 8,484 8,448 8,363
P/E ratio 26.8 x -6.57 x 28.9 x 27.6 x -324 x 20.8 x 18.5 x 16.3 x
Yield - - - - - - - -
Capitalization / Revenue 0.95 x 1.39 x 2.36 x 2.87 x 2.45 x 2.11 x 1.92 x 1.76 x
EV / Revenue 1.92 x 2.25 x 2.95 x 3.36 x 2.88 x 2.63 x 2.39 x 2.16 x
EV / EBITDA 10.2 x 11.2 x 12.2 x 14.3 x 12.5 x 11.3 x 10.1 x 9.08 x
EV / FCF 124 x 16.3 x 52.6 x 104 x 221 x -160 x 188 x 61.9 x
FCF Yield 0.81% 6.13% 1.9% 0.96% 0.45% -0.62% 0.53% 1.61%
Price to Book 1.16 x 2.33 x 2.15 x 2.63 x - 2.25 x 1.97 x 1.76 x
Nbr of stocks (in thousands) 88,570 88,991 89,936 90,977 92,216 92,428 - -
Reference price 2 33.22 50.26 60.70 82.32 77.76 73.59 73.59 73.59
Announcement Date 2/27/20 2/25/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,107 3,210 2,314 2,610 2,929 3,220 3,540 3,872
EBITDA 1 585.9 644.1 558.7 615.1 677.7 753.5 833.6 920.9
EBIT 1 404.5 548.9 452 475.9 545.3 577.3 637.8 721
Operating Margin 13.02% 17.1% 19.53% 18.23% 18.62% 17.93% 18.02% 18.62%
Earnings before Tax (EBT) 1 136 -626.2 275.8 374.1 -25.36 434.9 490.1 532.7
Net income 1 108.9 -672.1 190.6 273.1 -21.67 328.3 371.9 418.7
Net margin 3.51% -20.94% 8.24% 10.46% -0.74% 10.2% 10.51% 10.81%
EPS 2 1.240 -7.650 2.100 2.980 -0.2400 3.540 3.977 4.520
Free Cash Flow 1 48.22 442.2 129.7 84.42 38.21 -52.87 44.87 135
FCF margin 1.55% 13.78% 5.6% 3.23% 1.3% -1.64% 1.27% 3.49%
FCF Conversion (EBITDA) 8.23% 68.65% 23.21% 13.72% 5.64% - 5.38% 14.66%
FCF Conversion (Net income) 44.27% - 68.02% 30.91% - - 12.07% 32.24%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/27/20 2/25/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 587.6 593.5 616.7 651.7 666.7 675.3 704.3 731.3 750.3 742.8 779.3 802.2 820.7 818.9 854.7
EBITDA 1 141.9 156.1 135.5 157.3 155.1 150.9 151.3 174.5 175.9 171.6 173.1 194.7 196.9 188.7 191.9
EBIT 1 114.1 127.7 106.6 128.2 125.5 115.5 119.7 142.5 142.5 136.2 130.4 151 152.9 143.2 146.4
Operating Margin 19.41% 21.52% 17.29% 19.67% 18.83% 17.11% 17% 19.48% 18.99% 18.33% 16.73% 18.82% 18.63% 17.48% 17.13%
Earnings before Tax (EBT) 1 85.31 96.13 79.31 109.7 97.1 88.07 85.64 96.43 -287.4 79.96 99.28 119.9 116 95.92 109.2
Net income 1 66.13 70.28 60.84 80.08 71.1 61.12 66.02 72.3 -217.7 57.73 74.84 89.15 87.85 76.49 81.83
Net margin 11.25% 11.84% 9.87% 12.29% 10.66% 9.05% 9.37% 9.89% -29.02% 7.77% 9.6% 11.11% 10.7% 9.34% 9.57%
EPS 2 0.7300 0.7700 0.6700 0.8800 0.7800 0.6700 0.7200 0.7900 -2.390 0.6300 0.8140 0.9640 0.9480 0.8080 0.8600
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 10/28/21 2/28/22 5/3/22 7/27/22 10/31/22 2/27/23 4/26/23 7/27/23 11/2/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,025 2,744 1,363 1,288 1,272 1,682 1,646 1,561
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5.163 x 4.26 x 2.44 x 2.094 x 1.877 x 2.232 x 1.974 x 1.695 x
Free Cash Flow 1 48.2 442 130 84.4 38.2 -52.9 44.9 135
ROE (net income / shareholders' equity) 7.4% 11.2% 8.63% 10.9% 11.4% 11.2% 11.7% 11.6%
ROA (Net income/ Total Assets) 2.74% 3.68% 3.38% 5.97% 6.19% 5.75% 5.92% 6.28%
Assets 1 3,968 -18,264 5,634 4,579 -350.1 5,714 6,282 6,670
Book Value Per Share 2 28.60 21.60 28.30 31.30 - 32.80 37.30 41.70
Cash Flow per Share 2 3.790 7.440 4.120 4.160 5.080 5.970 6.540 7.500
Capex 1 285 217 245 296 424 558 539 532
Capex / Sales 9.16% 6.75% 10.58% 11.34% 14.48% 17.32% 15.22% 13.74%
Announcement Date 2/27/20 2/25/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Acadia Healthcare Company, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
73.59 USD
Average target price
95.85 USD
Spread / Average Target
+30.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ACADIA HEALTHCARE COMPANY, INC. Stock Acadia Healthcare Company, Inc.
-5.36% 6.8B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ACHC Stock
  4. Financials Acadia Healthcare Company, Inc.